{
    "address1": "3838 West Parkway Boulevard",
    "city": "Salt Lake City",
    "state": "UT",
    "zip": "84120",
    "country": "United States",
    "phone": "801 954 7100",
    "fax": "801 954 7300",
    "website": "https://www.usana.com",
    "industry": "Packaged Foods",
    "industryDisp": "Packaged Foods",
    "sector": "Consumer Defensive",
    "sectorDisp": "Consumer Defensive",
    "longBusinessSummary": "USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.",
    "fullTimeEmployees": 1900,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Mr. Kevin G. Guest",
            "age": 59,
            "title": "Exec. Chairman",
            "yearBorn": 1963,
            "fiscalYear": 2022,
            "totalPay": 1287124,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Jim  Brown",
            "age": 53,
            "title": "CEO & Pres",
            "yearBorn": 1969,
            "fiscalYear": 2022,
            "totalPay": 790561,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. G. Douglas Hekking",
            "age": 52,
            "title": "Chief Financial Officer",
            "yearBorn": 1970,
            "fiscalYear": 2022,
            "totalPay": 648806,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Walter  Noot",
            "age": 56,
            "title": "Chief Operating Officer",
            "yearBorn": 1966,
            "fiscalYear": 2022,
            "totalPay": 624562,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. David  Mulham",
            "age": 62,
            "title": "Chief Sales Officer",
            "yearBorn": 1960,
            "fiscalYear": 2022,
            "totalPay": 601721,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Myron W. Wentz",
            "age": 81,
            "title": "Founder & Chairman Emeritus",
            "yearBorn": 1941,
            "fiscalYear": 2020,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. John  Cuomo",
            "title": "Exec. Director of Product Devel. & Technology",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Robert A. Sinnott M.N.S., Ph.D.",
            "age": 57,
            "title": "Chief Scientific Officer",
            "yearBorn": 1965,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Patrique  Richards",
            "title": "Exec. Director of Investor Relations & Bus. Devel.",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. P. Joshua Foukas",
            "age": 46,
            "title": "Chief Legal Officer, Gen. Counsel & Corp. Sec.",
            "yearBorn": 1976,
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 6,
    "boardRisk": 6,
    "compensationRisk": 7,
    "shareHolderRightsRisk": 2,
    "overallRisk": 5,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 59.96,
    "open": 60.18,
    "dayLow": 58.275,
    "dayHigh": 60.18,
    "regularMarketPreviousClose": 59.96,
    "regularMarketOpen": 60.18,
    "regularMarketDayLow": 58.275,
    "regularMarketDayHigh": 60.18,
    "payoutRatio": 0.0,
    "beta": 0.756915,
    "trailingPE": 18.256248,
    "forwardPE": 15.874999,
    "volume": 50094,
    "regularMarketVolume": 50094,
    "averageVolume": 68120,
    "averageVolume10days": 64830,
    "averageDailyVolume10Day": 64830,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 900,
    "askSize": 900,
    "marketCap": 1127605248,
    "fiftyTwoWeekLow": 48.61,
    "fiftyTwoWeekHigh": 69.6,
    "priceToSalesTrailing12Months": 1.1896803,
    "fiftyDayAverage": 63.5322,
    "twoHundredDayAverage": 60.9729,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 827424064,
    "profitMargins": 0.06689,
    "floatShares": 10052534,
    "sharesOutstanding": 19301700,
    "sharesShort": 223969,
    "sharesShortPriorMonth": 224460,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.0116,
    "heldPercentInsiders": 0.41601002,
    "heldPercentInstitutions": 0.56001,
    "shortRatio": 3.35,
    "shortPercentOfFloat": 0.0241,
    "impliedSharesOutstanding": 19301700,
    "bookValue": 24.294,
    "priceToBook": 2.4047089,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688169600,
    "earningsQuarterlyGrowth": -0.097,
    "netIncomeToCommon": 63399000,
    "trailingEps": 3.2,
    "forwardEps": 3.68,
    "pegRatio": 1.24,
    "lastSplitFactor": "2:1",
    "lastSplitDate": 1479859200,
    "enterpriseToRevenue": 0.873,
    "enterpriseToEbitda": 7.542,
    "52WeekChange": -0.08360785,
    "SandP52WeekChange": 0.08443928,
    "exchange": "NYQ",
    "quoteType": "EQUITY",
    "symbol": "USNA",
    "underlyingSymbol": "USNA",
    "shortName": "USANA Health Sciences, Inc.",
    "longName": "USANA Health Sciences, Inc.",
    "firstTradeDateEpochUtc": 765466200,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "uuid": "e60428ae-057a-325e-b132-f070e079f759",
    "messageBoardId": "finmb_367118",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 58.42,
    "targetHighPrice": 74.0,
    "targetLowPrice": 62.0,
    "targetMeanPrice": 68.0,
    "targetMedianPrice": 68.0,
    "recommendationMean": 3.0,
    "recommendationKey": "hold",
    "numberOfAnalystOpinions": 2,
    "totalCash": 300183008,
    "totalCashPerShare": 15.552,
    "ebitda": 109710000,
    "totalDebt": 0,
    "quickRatio": 2.637,
    "currentRatio": 3.405,
    "totalRevenue": 947822016,
    "revenuePerShare": 49.203,
    "returnOnAssets": 0.10385,
    "returnOnEquity": 0.14533,
    "grossProfits": 804711000,
    "freeCashflow": 87085000,
    "operatingCashflow": 91972000,
    "earningsGrowth": -0.107,
    "revenueGrowth": -0.099,
    "grossMargins": 0.80499,
    "ebitdaMargins": 0.11575,
    "operatingMargins": 0.101730004,
    "financialCurrency": "USD",
    "trailingPegRatio": 1.3158,
    "parent_etfs": [
        "BFIT"
    ]
}